Ikonisys SA ALIKO.PA
€1.50 €0.04 (2.60%) 1D
Last Updated: Jun 12, 12:00 AM·XPAR
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
ALIKO.PA Shariah Compliance
Screening Methodology: AAOIFI
DOUBTFUL
Last Updated: September 12, 2024
Report Source: 2023 Annual Report
Ikonisys SA. Stock Analysis ALIKO.PA
France Health Care Nano Cap Report: Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Read More Ikonisys SA (ALIKO.PA) Chart
Key Statistics of Ikonisys SA (ALIKO.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€1.54Volume
4252.00P/E Ratio (TTM)
-52 Week Range
Market Cap
24.95MAvg. Volume
7999.87Dividend Yield
-Financial Metrics & Statements of Ikonisys SA (ALIKO.PA)
FAQ's for Ikonisys SA (ALIKO.PA)
- According to Musaffa’s Shariah screening methodology, Ikonisys SA (ALIKO.PA) is currently classified as DOUBTFUL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ikonisys SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ikonisys SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ikonisys SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ikonisys SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ikonisys SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.